Home Cart 0 Sign in  

[ CAS No. 937591-69-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 937591-69-0
Chemical Structure| 937591-69-0
Structure of 937591-69-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 937591-69-0 ]

Related Doc. of [ 937591-69-0 ]

Alternatived Products of [ 937591-69-0 ]

Product Details of [ 937591-69-0 ]

CAS No. :937591-69-0 MDL No. :MFCD09743046
Formula : C14H19BO3 Boiling Point : -
Linear Structure Formula :- InChI Key :RWJUUXWJBMIGKA-UHFFFAOYSA-N
M.W : 246.11 Pubchem ID :16750469
Synonyms :

Calculated chemistry of [ 937591-69-0 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.57
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 72.26
TPSA : 27.69 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.74 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 2.91
Log Po/w (WLOGP) : 1.92
Log Po/w (MLOGP) : 1.67
Log Po/w (SILICOS-IT) : 2.38
Consensus Log Po/w : 1.78

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.38
Solubility : 0.103 mg/ml ; 0.000417 mol/l
Class : Soluble
Log S (Ali) : -3.15
Solubility : 0.173 mg/ml ; 0.000704 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.29
Solubility : 0.0125 mg/ml ; 0.0000508 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.01

Safety of [ 937591-69-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 937591-69-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 937591-69-0 ]

[ 937591-69-0 ] Synthesis Path-Downstream   1~7

YieldReaction ConditionsOperation in experiment
51% 5-(4,4,5,5-Tetramethyl[1,3,2]-dioxaborolan-2-yl)-2,3-dihydro-benzofuran The title compound, MS: m/e=246.1 (M') was obtained as a light yellow oil (51% yield) using 2,3-dihydro-5-iodobenzo[b]furan.
  • 2
  • [ 937591-69-0 ]
  • (S)-1-(4-iodophenyl)ethyl diisopropylcarbamate [ No CAS ]
  • (R)-2-(1-(benzofuran-5-yl)-1-(4-iodophenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane [ No CAS ]
  • 3
  • [ 937591-69-0 ]
  • 5-bromo-7-chloroquinoxaline [ No CAS ]
  • 7-chloro-5-(2,3-dihydro-1-benzofuran-5-yl)quinoxaline [ No CAS ]
YieldReaction ConditionsOperation in experiment
17% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; caesium carbonate; In 1,2-dimethoxyethane; water; at 100℃; for 1.0h;Inert atmosphere; Sealed tube; A pressure vessel is charged with 5-bromo-7-chloro-quinoxaline (Intermediate 2 (288 mg, 1 .18 mmol, 1 eq.), 5-(4,4,5,5-tetramethyl- [1 ,3,2]dioxaborolan-2-yl)-2,3-dihydrobenzofuran (306 mg; 1.18 mmol; 1 eq.), cesium carbonate (779 mg; 2.37 mmol; 2 eq.), 1 ,2-dimethoxyethane (10 mL) and water (5 mL). The reaction mixture is sparged with argon under sonication before Pd(dppf)Cl2*CH2CI2 (148 mg; 0.18 mmol; 0.15 eq.) is added. The tube is sealed and the reaction mixture is stirred at 100 C for 1 h. After coming back to room temperature, the reaction mixture is partitioned between EtOAc and water. The aq. layer is extracted with EtOAc and the combined organic layers are washed with water and brine, dried over Na2S04 filtered through a pad of celite and concentrated in vacuo. Purification of the residue by FCC (EtOAc gradient in hexane) affords 7- chloro-5-(2,3-dihydro-1-benzofuran-5-yl)quinoxaline (58 mg; 0.20 mmol; yield: 17%; off-white powder; UPLC purity: 97%)
  • 4
  • [ 937591-69-0 ]
  • [ 80-48-8 ]
  • [ 76429-68-0 ]
  • 5
  • [ 512-56-1 ]
  • [ 937591-69-0 ]
  • [ 76429-68-0 ]
  • 6
  • [ 937591-69-0 ]
  • [ 74-88-4 ]
  • [ 76429-68-0 ]
  • 7
  • [ 937591-69-0 ]
  • [ 460081-20-3 ]
  • [ 1528744-84-4 ]
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 937591-69-0 ]

Organoboron

Chemical Structure| 445303-12-8

[ 445303-12-8 ]

2-(2,3-Dihydrobenzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 754226-40-9

[ 754226-40-9 ]

2-(4-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.96

Chemical Structure| 765908-38-1

[ 765908-38-1 ]

2-(3-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.95

Chemical Structure| 1009303-77-8

[ 1009303-77-8 ]

2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenemethanol

Similarity: 0.92

Chemical Structure| 1002727-88-9

[ 1002727-88-9 ]

2-(Chroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.91

Related Parent Nucleus of
[ 937591-69-0 ]

Benzofurans

Chemical Structure| 445303-12-8

[ 445303-12-8 ]

2-(2,3-Dihydrobenzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 519054-55-8

[ 519054-55-8 ]

2-(Benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.91

Chemical Structure| 1192755-14-8

[ 1192755-14-8 ]

2-(Benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.87

Chemical Structure| 227305-69-3

[ 227305-69-3 ]

2,3-Dihydrobenzofuran-5-boronic acid

Similarity: 0.77

Chemical Structure| 763120-44-1

[ 763120-44-1 ]

(2,3-Dihydrobenzofuran-6-yl)boronic acid

Similarity: 0.76